Dundee Ultrasound Appeal

Funding Neuro is working with Dr Kismet Hossain-Ibrahim to raise funds to purchase an Insightec Ultrasound device. The combination of this device together with a chemical called ALA, provided by SonALAsense, an American company has been proven in safety trials in the USA to safely produce Sonodynamic therapy to reduce the size of cancer tumours within a patient’s skull. All without the need for invasive surgery! MHRA approval is currently being sought for this ground breaking trial. This trial will be set up to treat both DIPG and Glioblastoma patients.

Support our appeal

Help fund vital research.
Help save lives.

What is Glioblastoma?

Glioblastoma, also known as glioblastoma multiforme (GBM), is the most aggressive cancer that begins within the brain. Initially, signs and symptoms of glioblastoma are non-specific. They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke. There is no clear way to prevent the disease.

Dr John Howard Sampson, M.D., Ph.D, M.B.A, M.H.S.c, is the chief of the department of neurosurgery at Duke University where he serves as a professor of surgery, biomedical engineering, immunology, and pathology said “There have been surprisingly promising clinical outcomes in small studies of this investigational vaccine, which certainly support these advanced trials. Immunotherapy is giving real hope to those with glioblastoma.”

Read up on more information on glioblastoma.